3rd Quarter - Report

POLICY ADVOCATES for GLAXOSMITHKLINE

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Corporate Tax Reform Alternative minimum Tax reform Excise Tax Issues Health Care Extenders

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: SENATE; Administration for Children & Families (ACF); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Monitor Patent issues

LobbyistCovered position, as disclosed
VICTOR CABRAL —
JACK MARTIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Administration for Children & Families (ACF)

Health Issues HCR

Obamacare Repeal Health Care reform Chip Reauthorization

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Administration for Children & Families (ACF)

Medicare/Medicaid MMM

Health Care Reform Legislation HR1628 Access to Affordable Prescription Drugs Medicare Prescription Drug Price Negotiation Act HR 242 Protecting Medicare from executive Action S 251 Medicare Prescription Drug Price Negotiation Act S 41 Race for Children Act HR 1231

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Administration for Children & Families (ACF)

Bills named: H.R. 242 (115th), H.R. 1628 (115th), H.R. 1231 (115th)

Trade (domestic/foreign) TRD

USTR appointments Patent Protection NAFTA repeal and Renegotiation

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: HOUSE OF REPRESENTATIVES; Administration for Children & Families (ACF); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.